Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Syringe Driver Survey Database migration to MedicinesComplete - January 2023

Syringe Driver Survey Database has moved to MedicinesComplete and is no longer available on palliativedrugs.com.

It has been renamed to PCF’s Syringe Driver Database and is now accessed through Drug Compatibility Checker.

Drug Compatibility Checker, through MedicinesComplete is a new tool providing essential compatibility knowledge to support the administration of injectable drugs combining published data and clinical practice reports.

Find out more about Drug Compatibility Checker:https://about.medicinescomplete.com/publication/drug-compatibility-checker/

If you have a subscription to Palliative Care Formulary through MedicinesComplete, you will have access to PCF’s Syringe Driver Database through Drug Compatibility Checker, at no charge through 2023. 

To contribute to PCF’s Syringe Driver Database please continue to submit a clinical practice report using palliativedrugs.com here: https://www.palliativedrugs.com/syringe-driver-database.html

To learn more about a subscription to the Palliative Care Formulary through MedicinesComplete, please contact us here: https://info.medicinescomplete.com/sales

If you have any questions regarding access to PCF’s Syringe Driver Database or would like to renew your subscription to Palliative Care Formulary, please contact pharmpress-support@rpharms.com.


Joint position statement on the decision by WHO to withdraw guidance documents

23rd July 2019

Further to our news article in June regarding the decision of WHO to discontinue two pain management guidelines (click here to view), a joint position statement has been published and endorsed by many organizations, including IAHPC and EAPC. The statement urges:

  • WHO to revise and update the guidelines they have withdrawn with urgency and, until this task is completed, to reinstate both the withdrawn dcouments
  • Heads of state to continue to work with palliative care and pain experts and policy makers to ensure adequate access to internationally controlled essential medicines necesary for the relief of suffering, while preventing diversion and non-medical use.

Click here to view